Common Stock, Shares, Outstanding of Indaptus Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Indaptus Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Indaptus Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,641,920, a 84% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Indaptus Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,641,920 -8,554,964 -84% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 604,963 -7,948,084 -93% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 16,034,444 +7,495,561 +88% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 428,799 -7,972,248 -95% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 10,196,884 +1,795,837 +21% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 8,553,047 +152,000 +1.8% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 8,538,883 +137,836 +1.6% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 8,401,047 0 0% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 8,401,047 +142,450 +1.7% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 8,401,047 +142,450 +1.7% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 8,401,047 +142,450 +1.7% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 8,401,047 +142,450 +1.7% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 8,258,597 +125,354 +1.5% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 8,258,597 +6,399,854 +344% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 8,258,597 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 8,258,597 +6,313,925 +325% 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q3 2021 8,133,243 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 1,858,743 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q4 2020 1,944,672 31 Dec 2020 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.